Wondossen N. Sime

Medicon Village
Lund, M 22363, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological malignancies.

Journal: Frontiers in immunology

Published: September 23, 2025

Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy.

Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 02, 2024

An optimised Bcl-3 inhibitor for melanoma treatment.

An optimised Bcl-3 inhibitor for melanoma treatment.

Journal: British journal of pharmacology

Published: September 04, 2024

Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3.

Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3.

Journal: Cell death & disease

Published: December 19, 2023

Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.

Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells.

Journal: BMC cancer

Published: July 11, 2023

PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.

PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia.

Journal: Blood cancer journal

Published: July 03, 2023

Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis.

Journal: Science translational medicine

Published: October 12, 2022

Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma.

Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma.

Journal: Cancers

Published: May 25, 2021

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.

Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: March 03, 2021

Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration.

Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration.

Journal: Cancers

Published: January 19, 2021

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma.

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma.

Journal: International journal of molecular sciences

Published: July 27, 2020

Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.

Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.

Journal: International journal of molecular sciences

Published: July 27, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026